All data are based on the daily closing price as of May 19, 2025
h

Huons

243070.KQ
17.94 USD
-0.21
-1.16%

Overview

Last close
17.94 usd
Market cap
211.88M usd
52 week high
31.79 usd
52 week low
15.31 usd
Target price
38.44 usd

Valuation

P/E
N/A
Forward P/E
N/A
Price/Sales
0.5318
Price/Book Value
0.8988
Enterprise Value
276.69M usd
EV/Revenue
0.6784
EV/EBITDA
5.6566

Key financials

Revenue TTM
396.08M usd
Gross Profit TTM
202.01M usd
EBITDA TTM
51.74M usd
Earnings per Share
N/A usd
Dividend
0.44 usd
Total assets
443.77M usd
Net debt
N/A usd

About

Huons Co., Ltd. provides medical solutions for human health in Korea and internationally. The company offers oral solid form drugs, including circulatory system, metabolic, antipyretic, analgesic, anti-inflammatory, musculoskeletal system, digestive system, antihistamine, respiratory system, antibiotic, well-being, urogenital system, and other chemotherapeutic products; and injection products, such as anesthetic, antipyretic, analgesic, anti-inflammatory, skeletal muscle relaxant, antispasmodic, antihistamine, circulatory system, respiratory system, adrenocortical hormone, enzyme, mineral, solvent, calcium, hemostatic, antidote, antibiotic, metabolic, hyaluronic acid, well-being, anticoagulant, and other tissue cell system products. It also provides eye drop and bio products, as well as medical devices. The company was formerly known as Kwang Myung Pharm and changed its name to Huons Co., Ltd. in June 2003. Huons Co., Ltd. was founded in 1965 and is headquartered in Seongnam-si, South Korea.
  • Symbol
    243070.KQ
  • Exchange
    KQ
  • Isin
    KR7243070000
  • Country
    South Korea
  • Sector
    Healthcare
  • Industry
    Drug Manufacturers - Specialty & Generic
  • CEO
  • Headquarter
    Seongnam-si
  • Web site
    https://www.huons.com
Jakota Newsletter

Stay ahead in the JAKOTA stock markets with our roundup of vital insights

Icon scroll to top